MedicarePartD.guide

A non-government resource built from CMS public data

COVID-19 and flu antivirals on AARP Medicare Rx Preferred from UHC (S5921-383)

Paxlovid, Lagevrio, oseltamivir and Xofluza, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Florida
Premium
$119.10/month
Deductible
$130.00, doesn't apply to tier 1 and 2
Change plan

4 of 4 COVID and flu antivirals are covered on this plan. None require prior authorization.

  • Paxlovid
    nirmatrelvir and ritonavir
    Covered
    from $2,936.13
    Tier 5
  • Lagevrio
    molnupiravir
    Covered
    $1,099.05
    Tier 3
  • oseltamivir
    generic Tamiflu
    Covered
    from $14.45
    Tier 3
  • Xofluza
    baloxavir marboxil
    Covered
    from $29.33
    Tier 3

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list